IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
Presented positive data showing continued durable complete remissions (CR) achieved in 100% of evaluable leukemia patients in Phase 1 investigator-sponsored trial of INB-100 at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition …